scispace - formally typeset
C

Christopher J. Ormandy

Researcher at Garvan Institute of Medical Research

Publications -  136
Citations -  9544

Christopher J. Ormandy is an academic researcher from Garvan Institute of Medical Research. The author has contributed to research in topics: Prolactin & Breast cancer. The author has an hindex of 54, co-authored 131 publications receiving 8757 citations. Previous affiliations of Christopher J. Ormandy include St. Vincent's Health System & French Institute of Health and Medical Research.

Papers
More filters
Journal ArticleDOI

Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse.

TL;DR: This work establishes the prolactin receptor as a key regulator of mammalian reproduction, and provides the first total ablation model to further study the role of the prolACTin receptor and its ligands.
Journal ArticleDOI

Prolactin controls mammary gland development via direct and indirect mechanisms

TL;DR: Prolactin affects mammary morphogenesis in two different ways: it controls ductal side branching and terminal end bud regression in virgin animals via indirect mechanisms, but acts directly on the mammary epithelium to produce lobuloalveolar development during pregnancy.
Journal ArticleDOI

Null mutation of the prolactin receptor gene produces a defect in maternal behavior.

TL;DR: The PRLR is established as a regulator of maternal behavior in mice carrying a germ line null mutation of the PRL receptor (PRLR) gene, and eating, locomotor activity, sexual behavior, and exploration are normal in PRLR mutant mice.
Journal ArticleDOI

Cyclin D1, EMS1 and 11q13 amplification in breast cancer.

TL;DR: Although the region harbors several genes with known or suspected oncogenic potential, the complex structure of the amplicons and the fact that 11q13 is gene-rich have made definitive identification of specific genes that contribute to the genesis and progression of breast cancer a difficult and continuing process.